AR005350A1 - Una substancia activa biorreguladora, usos de la misma, metodos para producirla y aislarla, agente farmaceutico que comprende dicha substancia,agentes de diagnostico y metodos para el diagnostico de enfermedades - Google Patents
Una substancia activa biorreguladora, usos de la misma, metodos para producirla y aislarla, agente farmaceutico que comprende dicha substancia,agentes de diagnostico y metodos para el diagnostico de enfermedadesInfo
- Publication number
- AR005350A1 AR005350A1 ARP970100019A ARP970100019A AR005350A1 AR 005350 A1 AR005350 A1 AR 005350A1 AR P970100019 A ARP970100019 A AR P970100019A AR P970100019 A ARP970100019 A AR P970100019A AR 005350 A1 AR005350 A1 AR 005350A1
- Authority
- AR
- Argentina
- Prior art keywords
- substance
- methods
- active substances
- active
- bioregulating
- Prior art date
Links
- 239000000126 substance Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000000032 diagnostic agent Substances 0.000 title 1
- 229940039227 diagnostic agent Drugs 0.000 title 1
- 238000002405 diagnostic procedure Methods 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000008177 pharmaceutical agent Substances 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 5
- 230000001164 bioregulatory effect Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- GNEVIACKFGQMHB-UHFFFAOYSA-N carbon suboxide Chemical compound O=C=C=C=O GNEVIACKFGQMHB-UHFFFAOYSA-N 0.000 abstract 1
- 238000012512 characterization method Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 239000013385 inorganic framework Substances 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Inorganic Chemistry (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19600301A DE19600301C2 (de) | 1996-01-05 | 1996-01-05 | Durch Cyclooligomerisierung des einfachen Kohlensuboxids C¶3¶O¶2¶ aufgebaute makrocyclische Verbindungen, Verfahren zu deren Herstellung und Gewinnung sowie deren Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR005350A1 true AR005350A1 (es) | 1999-04-28 |
Family
ID=7782233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970100019A AR005350A1 (es) | 1996-01-05 | 1997-01-03 | Una substancia activa biorreguladora, usos de la misma, metodos para producirla y aislarla, agente farmaceutico que comprende dicha substancia,agentes de diagnostico y metodos para el diagnostico de enfermedades |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6187810B1 (Direct) |
| EP (1) | EP0874851B1 (Direct) |
| JP (1) | JP4195089B2 (Direct) |
| KR (1) | KR19990077000A (Direct) |
| CN (1) | CN1209132A (Direct) |
| AR (1) | AR005350A1 (Direct) |
| AT (1) | ATE233768T1 (Direct) |
| AU (1) | AU1307497A (Direct) |
| BG (1) | BG102599A (Direct) |
| BR (1) | BR9612430A (Direct) |
| CA (1) | CA2241870A1 (Direct) |
| CZ (1) | CZ208898A3 (Direct) |
| DE (2) | DE19600301C2 (Direct) |
| EE (1) | EE9800211A (Direct) |
| ES (1) | ES2194128T3 (Direct) |
| HR (1) | HRP970002A2 (Direct) |
| HU (1) | HUP9904191A2 (Direct) |
| IL (1) | IL125165A0 (Direct) |
| JO (1) | JO1945B1 (Direct) |
| PL (1) | PL327657A1 (Direct) |
| SI (1) | SI0874851T1 (Direct) |
| SK (1) | SK88598A3 (Direct) |
| TR (1) | TR199801288T2 (Direct) |
| TW (1) | TW376386B (Direct) |
| WO (1) | WO1997025333A2 (Direct) |
| ZA (1) | ZA9714B (Direct) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO280796A0 (en) * | 1996-10-07 | 1996-10-31 | Austin Research Institute, The | Methods of activating or enhancing FC receptors |
| DE10260537A1 (de) | 2002-12-21 | 2004-07-15 | Kerek, Franz, Dr. | Peptide mit hohem Cysteingehalt |
| US20060067055A1 (en) * | 2004-09-30 | 2006-03-30 | Heffner Kenneth H | Thermally conductive composite and uses for microelectronic packaging |
| EP1794223A1 (en) * | 2004-09-30 | 2007-06-13 | Honeywell International Inc. | Thermally conductive composite and uses for microelectronic packaging |
| CN119081077B (zh) * | 2024-09-26 | 2025-12-26 | 清华大学 | 一种聚吡喃酮、制备方法及应用 |
| CN119613750B (zh) * | 2024-12-10 | 2025-08-12 | 杭州师范大学 | 一种机械及pH双重调控的蝶形钾离子通道分子及其制备方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2565115A (en) | 1948-10-28 | 1951-08-21 | Squibb & Sons Inc | Method of obtaining a conjugated estrogen preparation |
| US2720483A (en) | 1951-02-21 | 1955-10-11 | Olin Mathieson | Method of obtaining a conjugatedestrogen preparation |
-
1996
- 1996-01-05 DE DE19600301A patent/DE19600301C2/de not_active Expired - Fee Related
- 1996-12-18 TW TW085115731A patent/TW376386B/zh active
- 1996-12-23 JO JO19961945A patent/JO1945B1/en active
- 1996-12-30 US US09/101,401 patent/US6187810B1/en not_active Expired - Fee Related
- 1996-12-30 ES ES96944678T patent/ES2194128T3/es not_active Expired - Lifetime
- 1996-12-30 DE DE69626548T patent/DE69626548T2/de not_active Expired - Lifetime
- 1996-12-30 SK SK885-98A patent/SK88598A3/sk unknown
- 1996-12-30 KR KR1019980705130A patent/KR19990077000A/ko not_active Ceased
- 1996-12-30 AU AU13074/97A patent/AU1307497A/en not_active Abandoned
- 1996-12-30 HU HU9904191A patent/HUP9904191A2/hu unknown
- 1996-12-30 IL IL12516596A patent/IL125165A0/xx unknown
- 1996-12-30 WO PCT/EP1996/005867 patent/WO1997025333A2/en not_active Ceased
- 1996-12-30 AT AT96944678T patent/ATE233768T1/de not_active IP Right Cessation
- 1996-12-30 EE EE9800211A patent/EE9800211A/xx unknown
- 1996-12-30 TR TR1998/01288T patent/TR199801288T2/xx unknown
- 1996-12-30 CZ CZ982088A patent/CZ208898A3/cs unknown
- 1996-12-30 EP EP96944678A patent/EP0874851B1/en not_active Expired - Lifetime
- 1996-12-30 PL PL96327657A patent/PL327657A1/xx unknown
- 1996-12-30 JP JP52482597A patent/JP4195089B2/ja not_active Expired - Fee Related
- 1996-12-30 SI SI9630605T patent/SI0874851T1/xx unknown
- 1996-12-30 BR BR9612430-0A patent/BR9612430A/pt unknown
- 1996-12-30 CN CN96180086A patent/CN1209132A/zh active Pending
- 1996-12-30 CA CA002241870A patent/CA2241870A1/en not_active Abandoned
-
1997
- 1997-01-02 ZA ZA9714A patent/ZA9714B/xx unknown
- 1997-01-03 AR ARP970100019A patent/AR005350A1/es unknown
- 1997-01-03 HR HR19600301.6A patent/HRP970002A2/hr not_active Application Discontinuation
-
1998
- 1998-07-03 BG BG102599A patent/BG102599A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE233768T1 (de) | 2003-03-15 |
| HUP9904191A2 (hu) | 2000-05-28 |
| HRP970002A2 (en) | 1998-04-30 |
| CA2241870A1 (en) | 1997-07-17 |
| BG102599A (en) | 1999-03-31 |
| TW376386B (en) | 1999-12-11 |
| DE69626548T2 (de) | 2003-12-24 |
| JP4195089B2 (ja) | 2008-12-10 |
| DE19600301A1 (de) | 1997-07-10 |
| JO1945B1 (en) | 1997-12-15 |
| JP2000503015A (ja) | 2000-03-14 |
| EP0874851B1 (en) | 2003-03-05 |
| TR199801288T2 (xx) | 1998-11-23 |
| BR9612430A (pt) | 1999-12-28 |
| WO1997025333A3 (en) | 1997-12-24 |
| US6187810B1 (en) | 2001-02-13 |
| CN1209132A (zh) | 1999-02-24 |
| AU1307497A (en) | 1997-08-01 |
| SK88598A3 (en) | 1998-12-02 |
| EE9800211A (et) | 1998-12-15 |
| IL125165A0 (en) | 1999-01-26 |
| EP0874851A2 (en) | 1998-11-04 |
| CZ208898A3 (cs) | 1998-10-14 |
| ES2194128T3 (es) | 2003-11-16 |
| SI0874851T1 (en) | 2003-10-31 |
| DE19600301C2 (de) | 1999-12-09 |
| DE69626548D1 (de) | 2003-04-10 |
| ZA9714B (en) | 1997-07-23 |
| PL327657A1 (en) | 1998-12-21 |
| KR19990077000A (ko) | 1999-10-25 |
| WO1997025333A2 (en) | 1997-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR003427A1 (es) | Péptidos relacionados con dolastatina, procedimiento para prepararlos, composiciones farmacéuticas que los contienen y el uso de los mismos para la preparación de dichas composiciones farmacéuticas. | |
| BR0215052A (pt) | Composições acaricidas e métodos | |
| IS4083A (is) | Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja | |
| ES2178430T3 (es) | Utilizacion de composiciones farmaceuticas gelificables en parodontologia. | |
| DE69713526D1 (de) | Lösliche prodrugs von paclitaxel | |
| ES2188652T3 (es) | Sistema de direccionado de farmacos, metodos de fabricacion y uso del mismo. | |
| AR024516A1 (es) | Compuestos bi-aromaticos analogos de la vitamina d, su utilizacion, composicion farmaceutica y composicion cosmetica que comprenden al menos uno de dichos compuestos y utilizacion de dicha composicion cosmetica. | |
| MX9305444A (es) | Derivados de rodanina como agentes hipoglucemicos y para el tratamiento de la enfermedad de alzheimer, composiciones farmaceuticas que los contienen y procedimiento para su preparacion. | |
| AR025959A1 (es) | DERIVADOS DE TER.-BUTIL-(7-METIL-IMIDAZO[1,2,a]PIRIDIN-3-IL)-AMINA, PROCEDIMIENTO PARA SU PREPARACION, MEDICAMENTOS QUE LOS CONTIENEN, SU USO PARA LAPREPARACION DE UN MEDICAMENTO PARA LA INHIBICION DE NO-SINTASA Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN | |
| ES2153483T3 (es) | Metodos y composiciones para la coagulacion especifica en los vasos tumorales. | |
| BR9807055A (pt) | Composição farmacêutica, uso de um agente fotoquimioterapêutico precursor da protoporfirina junto com um fotossensibilizador de localização de estroma vascular, produto contendo os mesmos, kit para uso em fotoquimioterapia de distúrbios ou anormalidades das superfìcies externa ou interna do corpo, e, processos de tratamento fotoquimioterapêutico de distúrbios ou anormalidades de superfìcies externa ou interna do corpo, e de diagnóstico in vitro de anormalidades ou distúrbios, mediante ensaios de uma amostra de fluidos corporais ou tecidos de um paciente | |
| HN1999000080A (es) | Derivados de isotiazol utiles como agentes anticancerosos. | |
| ATE337019T1 (de) | Geladene lipide und deren verwendung | |
| ECSP034883A (es) | Amidas de acidos antranilicos con cadena lateral de heteroarilsulfonilo, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como preparados farmaceuticos que las contienen | |
| DK0781281T3 (da) | Beta-Carbolinderivater som melatonin-agonister, fremgangsmåder til fremstilling deraf og deres anvendelse som lægemiddel | |
| DE59310310D1 (de) | 3-,8-substituierte deuteroporphyrinderivate, diese enthaltende pharmazeutische mittel und verfahren zu ihrer herstellung | |
| HN1999000146A (es) | Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas. | |
| ES2194054T3 (es) | Compuestos de lactona macrociclica y su procedimiento de produccion. | |
| ES2126618T3 (es) | Procedimiento para el aislamiento y cultivo de celulas transformadas asi como empleo de estas celulas para la obtencion de anticuerpos especificos para el individuo. | |
| AR024440A1 (es) | AGONISTAS DEL RECEPTOR A2A DE ETER PROPARGIL FENILICO, COMPOSICIoN FARMACEUTICA Y EL USO DE LOS MISMOS PARA PREPARAR UN MEDICAMENTO. | |
| AR006401A1 (es) | Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos. | |
| ES2038270T3 (es) | Preparaciones topicas sebosupresoras. | |
| ES2165948T3 (es) | Modificacion cristalina termoestable y apta para almacenaje de n-metil-n-((1s)-1-fenil-2-((3s)-3-hidroxi-pirrolidin-1-il)-etil)-2,2-difenil-acetamida, y procedimiento para su obtencion. | |
| AR005102A1 (es) | Compuestos derivados de octahidro-pirrolo [1,2-a]-pirazina 2,7-sustituidos, composiciones farmaceuticas y uso de dichos compuestos para la fabricacion deun medicamento. | |
| ES2134267T3 (es) | 1alfa,24(s)-dihidroxi vitamina d2, su preparacion y utilizacion. |